Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Trial of Baricitinib in Patients With Cardiac SarcoidosisHemic and Lymphatic Diseases, Hypersensitivity, Delayed, cardiac sarcoidosis, immune system disorder, lymphatic system disorder, lymphoproliferative syndrome, sarcoidosisNot yet recruitingPhase 22026-02-10NCT06868381

2 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Eli Lilly and Company370
Stanford University620

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Stanford UniversityPalo AltoUnited States2